2Deguchi T, Yasuda M, Nakano M, et al. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother, 1996, 40 (10) :2437 - 2438.
3Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother, 2001,45(12) :3603 - 3606.
4Moodley P, Pillay C, Goga R, et al. Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period : impact of the introduction of syndromic management. J Antimicrob Chemother, 2001,48 (6) :853 - 859.
5Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol, 2002, 184 ( 20 ) :5619 - 5624.
6Berglund T, Unemo M, Olcen P, et al. One year of Neisseria gonorrhoeae isolates in Sweden : the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS, 2002, 13(2) :109 - 114.
7Dillon JA, Li H, Sealy J, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. Sex Transm Dis, 2001, 28 (9):508 - 514.
8Roberts MC, Chung WO, Roe D, et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother, 1999, 43 (6) :1367 -1372.
9Ng LK, Martin I, Liu G,et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother, 2002, 46 (9) :3020 - 3025.
10Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother, 2000, 44(5) :1365 - 1366.
